MRD / Regn No. : TL/20-21/01053 Date : 16/06/2026
Patient Name : Shagorika Ghosh Age & Gender : 34 Yrs. / Female
Contact No. : 9321759621 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NONE Referred By :
   
Problem List : T2DM (03/Dec/2022) |
Subjective : PCOS SEVERAL YEARS / OLIGMENORRHEA / ACNE +,T2DM DETECTED IN JUNE 2022,MOVED BACK TO INDIA SUDDENLY,TRAUMATIC EXPERIENCE - STILL PROCESSING IT,LSM WERE DIFFICULT TO FOLLOW AND STOPPED RYBELSUS BEFORE DIWALI,WILL RESTART RYBELSUS / RESTARTED LSM NOW
Objective : JUN 26- HB-14.5/HBA1C-4.9/FBS- 77/PP- 84,TC- 274/TG- 124/LDL- 207/HDL- 42
S# Generic (Trade) Name Route Dosage Usage Duration
1 ROSUVASTATIN 20 MG
CRESTOR 20 MG 		ORAL 0-0-1 AD
 4 MTHS
2 ADILIP 135 ORAL 0-0-1 AD
 4 MTHS
3 TABLET SEMAGLUTIDE 3MG
RYBELSUS 3 MG 		ORAL 1-0-0 BBF
 10 DAYS
4 RYBELSUS 7 MG ORAL 1-0-0 BBF
 20 DAYS
5 TABLET SEMAGLUTIDE 14MG
RYBELSUS 14 MG 		ORAL 1-0-0 BBF
 TO CONTINUE
6 PRIMOLUT - N ORAL 1-0-1 ABF / AD
 5 DAYS IF PERIOD DELAYED BEYOND 45 DAYS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 04/Apr/2026
Tests Suggested For Next Visit : HBA1C / LIPID PROFILE / AMH / FSH > 4 MTHS
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription

Powered By: